The ad goes on to tout Hims & Hers' weight loss drugs as less expensive alternatives to medications like Ozempic and Wegovy, ...

and the search is on for newer products that can improve on the weight loss achieved by Wegovy and Zepbound. Novo Nordisk is also developing an oral drug for obesity, amycretin, which also ...

The next FDA Commissioner could solve two big problems with one powerful policy: encourage independent testing of both ...

Right now, Novo Nordisk’s biggest challenge is their inability to meet the skyrocketing demand for GLP-1 products ... the next step in the evolution of Wegovy and Ozempic.

Novo Nordisk's obesity therapy Wegovy put in another strong sales performance ... pharmaceutical ingredients and finished injectable products – that will result in "continued periodic supply ...

Compounded semaglutide is legal, but it's not regulated in the same way as medications like Ozempic and Wegovy.

Compounded semaglutide is legal, but it's not regulated in the same way as medications like Ozempic and Wegovy.

Hims & Hers offers a copycat of the blockbuster weight-loss drug at a fraction of the cost. But it might be a short-lived ...

Customers are to be offered discounted weight loss treatments through insurance giant Vitality in a UK first. The group, ...

Compounded weight-loss medications, such as those promoted in the Hims & Hers commercial, aren’t approved by the Food and Drug Administration.